The healthcare sector is experiencing a significant transformation, fueled by technological advancements, evolving patient expectations, and an increasing emphasis on value-based care. The integration of digital health technologies, such as telemedicine, wearable devices, and remote patient monitoring, is revolutionizing how healthcare services are delivered. The rise of artificial intelligence (AI) in diagnostics, predictive analytics, and personalized medicine is enhancing treatment outcomes while reducing operational costs. Additionally, the expansion of biotechnology and genomics is paving the way for breakthroughs in precision medicine, gene therapy, and vaccine development. In response to the global health challenges, there is a significant push toward sustainable healthcare solutions, with a focus on reducing waste and optimizing resource utilization. The adoption of robotic surgeries, 3D-printed implants, and nanotechnology is reshaping patient care, offering minimally invasive and highly effective treatment options. Meanwhile, the growing demand for mental health solutions has emphasized developing innovative therapies and digital tools to address psychological well-being.
Navistrat Analytics provides comprehensive market research reports that delve into these transformative trends, offering actionable insights into the evolving landscape of the healthcare sector. From advancements in digital health to breakthroughs in biotechnology and robotic healthcare, our reports equip businesses with the knowledge to innovate and thrive.
Unlock the future of healthcare with our reports.
Photon counting computed tomography market size reached USD 87.3 million in 2025 and is expected to register a revenue CAGR of 27.7% during the forecast period. Photon-counting computed tomography (PCCT) is a novel sophisticated imaging technique that will revolutionize the traditional clinical use of computed tomography (CT). Photon-counting detectors divide the number of photons and incident X-ray energy spectrum into several energy bins. [...]
AI in endoscopy market size reached USD 1,668.5 million in 2025 and is expected to register a revenue CAGR of 24.8% during the forecast period. AI-based endoscopy technologies may improve the efficacy of endoscopic procedures. AI algorithms could enhance endoscopic operations by automating functions like as image processing and interpretation, saving both time and money. [...]
Genomic cancer panel profiling market size reached USD 8.87 billion in 2024 and is expected to register a revenue CAGR of 11.4% during the forecast period. A laboratory technique called genomic profiling examines the genetic material of cancer cells to find changes and mutations in hundreds of genes. This method assesses the DNA and RNA of tumors using cutting-edge instruments like next-generation sequencing (NGS), offering a comprehensive picture of their genetic landscape. [...]
The spine surgery robotics market size reached USD 325.6 million in 2024 and is expected to register a revenue CAGR of 12.7% during the forecast period. Robotic spine surgical systems convert spine surgery from freehand to highly accurate, cutting-edge robotic methods that require less radiation. It is utilized for operations such as minimally invasive surgery (MIS), scoliosis, and other difficult spinal deformities. Neurosurgeons and spine specialists can reach previously unheard-of precision, efficiency, and safety by using robotics into surgical procedures. [...]
Viral vector and plasmid manufacturing market size reached USD 5.25 billion in 2024 and is expected to register a revenue CAGR of 19.7% during the forecast period. The use of plasmid DNA in the creation of viral vectors for gene therapy is a significant achievement in medical science. Viral vectors, such as retroviral, adenoviral, and lentiviral vectors, are important in gene therapy because of their high transduction efficiency and sustained gene expression. [...]
The microbubbles/ultrasound contrast agents market size reached USD 1,542.6 Million in 2024 and is expected to register a revenue CAGR of 14.4% during the forecast period. In cardiology and radiology, microbubbles are utilized as blood pool agents in contrast ultrasonography imaging. [...]
The exosome diagnostic & therapeutic market size reached USD 82.6 Million in 2024 and is expected to register a revenue CAGR of 46.7% during the forecast period. Exosomes are a type of extracellular vesicle produced by all cells and are found in a variety of bodily fluids. Exosomes serve critical roles in tumour initiation and development, immunological suppression, immune surveillance, metabolic reprogramming, angiogenesis, and macrophage polarization. [...]
The decentralized clinical trials market size reached USD 8.87 billion in 2024 and is expected to register a revenue CAGR of 10.2% during the forecast period. A decentralized clinical trial (DCT) is one in which part or all trial-related activities take place in locations other than standard clinical trial sites. They can provide numerous benefits to pharmaceutical firms, including cost savings, greater patient recruitment and retention, and higher data quality. [...]
The self-amplifying RNA synthesis market size reached USD 107.8 million in 2024 and is expected to register a revenue CAGR of 20.3% during the forecast period. Self-amplifying mRNA, or saRNA, is a synthetic version of mRNA that can replicate itself. Unlike ordinary mRNA, which typically encodes a single protein, saRNA goes one step farther. It contains not only the genetic instructions for a given protein, but also the machinery required for self-replication. [...]
The high-level disinfection services market size reached USD 26.47 Billion in 2024 and is expected to register a revenue CAGR of 8.0% during the forecast period. High-level disinfection entails utilizing disinfectants capable of killing all microorganisms (except for a few bacterial spores) and inactivating any viruses found on used medical equipment. [...]
Whole-exome sequencing market size reached USD 440.6 million in 2024 and is expected to register a revenue CAGR of 18.1% during the forecast period. Whole exome sequencing (WES) is a next-generation sequencing (NGS) technique that concurrently tests the protein-coding sections of all patient's genes, commonly known as the exome. The exome comprises around 1% of a patient's genome. [...]
The global patient monitoring devices market size reached USD 48.3 billion in 2024 and is expected to register a revenue CAGR of 8.8% during the forecast period. Rising prevalence of chronic diseases, growing adoption of remote patient monitoring, and increasing demand for personalized healthcare solutions are key factors driving revenue growth in the patient monitoring devices market. [...]
[...]
Antibody-Drug Conjugates (ADCs) market size reached USD 12.83 Billion in 2024 and is expected to register a revenue CAGR of 14.9% during the forecast period. Antibody-drug conjugates (ADCs) are novel biopharmaceutical products in which a monoclonal antibody is coupled to a small molecule medication via a stable linker. Most ADCs created to date have been used to treat cancer, but there is huge promise for employing ADCs to treat other disorders. [...]
Preclinical Contract Research Organization (CRO) market size reached USD 8.79 Billion in 2024 and is expected to register a revenue CAGR of 12.7% during the forecast period. A preclinical CRO is a specialist organization that helps pharmaceutical and biotechnology businesses with early-stage drug development. Preclinical CROs provide a variety of services to bridge the gap between drug discovery and clinical trials. [...]